. .

 
Zuruecksetzen

Suchergebnis - CVS HEALTH CORP. REGISTERED SHARES DL-,01

Zeit Titel
21.09 15:53dpa-AFX: FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
19.09 17:47dpa-AFX: *CVS HEALTH CORP. (CVS) DECLARES QUARTERLY DIVIDEND OF $ 0.665, RECORD DATE 10/21/2024
19.09 17:14dpa-AFX: *CVS HEALTH BOARD APPROVES QUARTERLY DIVIDEND OF $0.665 CENTS/SHR; PAYABLE NOVEMBER 1/RECORD OCTOBER 21
12.09 15:46dpa-AFX: CVS Health Says Hormonal Contraceptive Prescribing Now Available At CVS Pharmacies In Massachusetts
12.09 15:13dpa-AFX: *CVS HEALTH SAYS HORMONAL CONTRACEPTIVE PRESCRIBING NOW AVAILABLE AT MASSACHUSETTS CVS PHARMACIES
28.08 15:17dpa-AFX: CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines
28.08 14:03dpa-AFX: *CVS ANNOUNCES AVAILABILITY OF UPDATED 2024-2025 COVID-19 AND FLU VACCINES AT CVS PHARMACY AND MINUTECLINIC LOCATIONS
14.08 22:06dpa-AFX: *CVS HEALTH NAMES HEIDI CAPOZZI AS EVP, CHIEF PEOPLE OFFICER
07.08 12:55dpa-AFX: *CVS HEALTH NOW EXPECTS FY24 GAAP EPS OF $4.95 TO $5.20, ADJ. EPS OF $6.40 TO $6.65
07.08 12:54dpa-AFX: *CVS HEALTH Q2 ADJ. EPS $1.83 VS. $2.21 LAST YEAR
07.08 12:54dpa-AFX: *CVS HEALTH Q2 TOTAL REVENUES $91.234 BLN VS. $88.921 BLN LAST YEAR
07.08 12:53dpa-AFX: *CVS HEALTH Q2 OPERATING INCOME $3.045 BLN VS. $3.234 BLN LAST YEAR
07.08 12:53dpa-AFX: *CVS HEALTH Q2 NET INCOME $1.770 BLN VS $1.901 BLN LAST YEAR
07.08 12:49dpa-AFX: ROUNDUP: CVS Health Cuts FY24 Earnings View Below Market; Stock Down In Pre-market
07.08 12:34dpa-AFX: CVS Health Corp. Q2 Profit Decreases, But Beats Estimates
07.08 12:32dpa-AFX: *CVS HEALTH Q2 GAAP EPS $1.41 VS. $1.48 LAST YEAR
07.08 12:02dpa-AFX: CVS Health Q2 24 Earnings Conference Call At 8:00 AM ET
06.08 19:33X verklagt Werbevereinigung wegen geschäftsschädigendem Boykott
08.07 15:19dpa-AFX: *CVS HEALTH CORP. (CVS) DECLARES QUARTERLY DIVIDEND OF $ 0.665, RECORD DATE 7/22/2024
08.07 15:18dpa-AFX: *CVS HEALTH DECLARES QUARTERLY DIVIDEND OF $0.665/SHR, PAYABLE AUG. 01, RECORD JULY 22

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH